of future sites for implants.

Int J Oral Maxillofac

Implants 1999;14:529–35. 48 Lee HR, Hong YJ, Chung S, et al. Proposal of standardized guidelines for the
66 Anitua E, Andía I, Sanchez M, et al. Autologous
preparations rich in growth factors production and quality control of autologous serum eye drops in Korea: based on a
promote proliferation and induce VEGF and HGF
production by human tendon cells nationwide survey. Transfusion 2014;54:1864–70.
67 Hartwig D, Harloff S, Liu L, et al. Epitheliotrophic
capacity of a growth factor nhsbt.nhs.uk/tissueservices/pdf/Autologous_Serum_Eyedrops_Service_leaflet%20_
preparation produced from platelet concentrates on
corneal epithelial cells: 21_10_2008.pdf (accessed Mar 2015).
a potential agent for the treatment of ocular surface
defects? Transfusion 50 Liu L, Hartwig D, Harloff S, et al. An optimised protocol for the production of
2004;44:1724–31. autologous serum eyedrops. Graefes
Arch Clin Exp Ophthalmol 2005;243:706–14. jgsbahikdnkaioyqiHBJAGIUGAIUGjjbdbfkjsjdfjdoiyhawnsmbbcjsgvhjfn
egfdigesjdfjbdsjfhjsdf jgfsdbisjdgfbjshdfjbeusjd